These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2354453)

  • 1. Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis.
    Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
    Cancer Res; 1990 Jul; 50(13):4032-7. PubMed ID: 2354453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
    Pollard RB; Schmitt DA; Sasaki H; Hayashi Y; Suzuki F
    Anticancer Res; 1990; 10(2A):285-90. PubMed ID: 2346302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
    Suzuki F; Brutkiewicz RR; Pollard RB
    J Natl Cancer Inst; 1986 Aug; 77(2):441-7. PubMed ID: 3090339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth by the intralesional administration of interleukin-3 into mice implanted with solid tumors.
    Sasaki H; Schmitt DA; Hayashi Y; Pollard RB; Suzuki F
    Anticancer Res; 1992; 12(2):313-5. PubMed ID: 1580549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Igarashi M; Kumagai K
    J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
    Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F
    Nat Immun; 1993; 12(2):104-12. PubMed ID: 8318815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis.
    Sasaki H; Schmitt DA; Kobayashi M; Hayashi Y; Pollard RB; Suzuki F
    Nat Immun; 1993; 12(3):152-64. PubMed ID: 8329838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM; Blazar BR; Bach FH; Ochoa AC
    J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM; Ju ST; Lu CY; Sy MS
    J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG-induced T cell anergy and its activation by IL-4].
    Nishioka Y; Nakanishi K; Sugita M
    Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice.
    Matsumura H; Nakano M
    J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
    Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.